Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1966]
News [3163]
Articles [130]
Editorials [3]
Conferences [121]
elearning [17]
Why are Immuno-Oncology compounds different?
Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain
Why are Immuno-Oncology compounds different? ( Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain )
3 Dec 2013
Immuno-Oncology: a concept or already a reality?
Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK
Immuno-Oncology: a concept or already a reality? ( Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK )
3 Dec 2013
Elderly population needs new definition to inform treatment decisions
Dr Reinhard Stauder, Prof Mario Boccadoro
Elderly population needs new definition to inform treatment decisions ( Dr Reinhard Stauder, Prof Mario Boccadoro )
27 Nov 2013
Expert care is needed for elderly haematology patients
Prof Matti Aapro, Dr Lodovico Balducci, Prof Mario Boccadoro, Prof Anders...
Expert care is needed for elderly haematology patients ( Prof Matti Aapro, Dr Lodovico Balducci, Prof Mario Boccadoro, Prof Anders Österborg )
27 Nov 2013
Aiding treatment of HIV and cancer with aspirin
Dr Andrew Freedman - National Cancer Institute, Bethesda, USA
Aiding treatment of HIV and cancer with aspirin ( Dr Andrew Freedman - National Cancer Institute, Bethesda, USA )
27 Nov 2013
ISIS 2 study: Use of aspirin to prevent cardiovascular problems
Dr Conrad Keating - University of Oxford, UK
ISIS 2 study: Use of aspirin to prevent cardiovascular problems ( Dr Conrad Keating - University of Oxford, UK )
27 Nov 2013
Engineering of polymeric nanoparticles for medical applications
Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013
The future of CLL treatment: balancing efficacy, safety and cost
Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA
The future of CLL treatment: balancing efficacy, safety and cost ( Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA )
14 Nov 2013
Making sense of the expanding armoury of treatment options for the less fit CLL...
Dr Valentin Goede - Uniklinik Köln, Cologne, Germany
Making sense of the expanding armoury of treatment options for the less fit CLL patient ( Dr Valentin Goede - Uniklinik Köln, Cologne, Germany )
14 Nov 2013
‘Go-Go’ CLL patients: a look towards the future
Professor Clemens Wendtner - Klinikum Schwabing, Munich, Germany
‘Go-Go’ CLL patients: a look towards the future ( Professor Clemens Wendtner - Klinikum Schwabing, Munich, Germany )
14 Nov 2013
The economic burden of CLL treatment now and in the future
Dr George Follows - Addenbrooke’s Hospital, Cambridge, UK
The economic burden of CLL treatment now and in the future ( Dr George Follows - Addenbrooke’s Hospital, Cambridge, UK )
14 Nov 2013
The future of CLL treatment: Balancing efficacy, safety, and cost: Introduction...
Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA
The future of CLL treatment: Balancing efficacy, safety, and cost: Introduction from the Chair ( Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA )
10 Nov 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation